Sage Therapeutics CEO Barry Greene's 2021 pay jumps 469% to $59M
Sage Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 28, 2022
Sage Therapeutics reported fiscal year 2021 executive compensation information on April 28, 2022.
In 2021, five executives at Sage Therapeutics received on average a compensation package of $14M, a 420% increase compared to previous year.
Average pay of disclosed executives at Sage Therapeutics
Barry E. Greene, Chief Executive Officer, received $59M in total, which increased by 7,026% compared to 2020. 98% of Greene's compensation, or $58M, was in option awards. Greene also received $502K in non-equity incentive plan, $735K in salary, as well as $12K in other compensation.
For fiscal year 2021, the median employee pay was $308,210 at Sage Therapeutics. Therefore, the ratio of Barry E. Greene's pay to the median employee pay was 191 to one.
Jeffrey M. Jonas, Chief Innovation Officer, received a compensation package of $4.1M, which decreased by 11% compared to previous year. 44% of the compensation package, or $1.8M, was in option awards.
Albert J. Robichaud, Chief Scientific Officer, earned $2.8M in 2021, a 31% increase compared to previous year.
Christopher Benecchi, Chief Commercial Officer, received $2.7M in 2021.
Kimi Iguchi, Chief Financial Officer, earned $2.4M in 2021, a 23% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 28, 2022.